The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Trofimov N.A.

Republican Cardiology Dispensary

Babokin V.E.

Republican Cardiology Dispensary;
Institute for Advanced Training of Physicians;
Ulyanov Chuvash State University

Egorov D.V.

Republican Cardiology Dispensary;
Ulyanov Chuvash State University

Dubova A.V.

Republican Cardiology Dispensary;
Ulyanov Chuvash State University

Nikolsky A.V.

Nizhny Novgorod Municipal Clinical Hospital No. 5

Tabaev R.G.

Republican Cardiology Dispensary

Rodionov A.L.

Republican Cardiology Dispensary

Dragunov A.G.

Republican Cardiology Dispensary

Nikolaeva O.V.

Republican Cardiology Dispensary

Zhamlikhanova S.S.

Ulyanov Chuvash State University

Treatment of myocarditis in COVID-19 patients

Authors:

Trofimov N.A., Babokin V.E., Egorov D.V., Dubova A.V., Nikolsky A.V., Tabaev R.G., Rodionov A.L., Dragunov A.G., Nikolaeva O.V., Zhamlikhanova S.S.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(2): 159‑166

DOI: 10.17116/kardio202215021159

Read: 3641 times

Contact the author
Table of contents

TREATMENT OF MYOCARDITIS IN COVID-19 PATIENTS
TREATMENT OF MYOCARDITIS IN COVID-19 PATIENTS

To cite this article:

Trofimov NA, Babokin VE, Egorov DV, et al. Treatment of myocarditis in COVID-19 patients. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(2):159‑166. (In Russ.)
https://doi.org/10.17116/kardio202215021159

 
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Atrial fibrillation and left ventricular dysfunction: cause or consequence (analysis of the dila­ted cardiomyopathy regi­stry). Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):619-627
Prediction of mortality in severe ischemic stroke during COVID-19 in patients with multiorgan dysfunction. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):120-127
Atte­ndance of oral surgeons per one inha­bitant per year in the subjects of the Russian Fede­ration in 2017—2023. Stomatology. 2025;(3):53-56
Sleep diso­rders after COVID-19 in patients with primary headaches. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):127-132
Atte­ndance of dental surgeons for diseases in the Russian Fede­ration in 2017—2023. Stomatology. 2025;(4):62-65
Sarcoid reaction with focal inte­rstitial fibrosis in a COVID-19 patient with persistence of Sars-Cov-2 virus nucleocapsid and adhe­sion proteins in sarcoid granulomas and lung tissue. Russian Journal of Archive of Pathology. 2025;(4):54-57
Effe­ctiveness and tole­rability of agomelatine (Valdoxan) in the treatment of depression after COVID-19 (TELESFOR study). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):90-98
Features of lung cancer carcinogenesis invo­lving cancer stem cells in COVID-19. Effe­cts of photodynamic therapy in the treatment of cancer and COVID-19. Russian Journal of Archive of Pathology. 2025;(5):65-73
Multimorbidity, risk factors and causes of death in patients with cardiovascular diseases during long-term posthospital moni­toring. Russian Journal of Preventive Medi­cine. 2025;(11):36-44
Coro­naviruses in human pathophysiology: a brief history of the COVID-19 pandemic. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(4-2):55-63
Abstract:

OBJECTIVE

To describe a few cases of COVID-19-associated myocardial damage, to analyze its pathogenesis, approaches to diagnosis and treatment.

MATERIAL AND METHODS

All our patients with myocarditis and a new coronavirus infection had life-threatening heart rhythm disturbances, including ventricular fibrillation with clinical death and subsequent intensive care, syncope following bradyarrhythmia in 2 cases, as well as atrial fibrillation with thrombosis of the right atrial appendage.

RESULTS

In all cases, specialized medical care saved patient lives, and appropriate therapy restored sinus rhythm and compensated heart failure. Heart rhythm disturbances in our patients were transient and regressed within 3 months. Specific drug therapy was carried out according to generally accepted approaches, and only 1 patient with sudden ventricular fibrillation and subsequent successful intensive care required implantable cardioverter-defibrillator.

CONCLUSION

Myocarditis following a new coronavirus infection may be accompanied by life-threatening heart rhythm disturbances with possible fatal outcomes in the absence of appropriate medical care. The features of myocarditis associated with SARS-CoV-2 infection may be a delayed nature of clinical manifestations or lightning-fast course with acute heart failure, arrhythmias, as well as transient damage with fast recovery throughout the treatment. Follow-up of patients with previous inflammatory myocardial lesions, analysis of other cases of COVID-19-associated myocarditis and a large sample are necessary for subsequent analysis.

Keywords:

COVID-19
myocarditis
heart rhythm disorders
cardiac complications

Authors:

Trofimov N.A.

Republican Cardiology Dispensary

Babokin V.E.

Republican Cardiology Dispensary;
Institute for Advanced Training of Physicians;
Ulyanov Chuvash State University

Egorov D.V.

Republican Cardiology Dispensary;
Ulyanov Chuvash State University

Dubova A.V.

Republican Cardiology Dispensary;
Ulyanov Chuvash State University

Nikolsky A.V.

Nizhny Novgorod Municipal Clinical Hospital No. 5

Tabaev R.G.

Republican Cardiology Dispensary

Rodionov A.L.

Republican Cardiology Dispensary

Dragunov A.G.

Republican Cardiology Dispensary

Nikolaeva O.V.

Republican Cardiology Dispensary

Zhamlikhanova S.S.

Ulyanov Chuvash State University

Received:

21.04.2021

Accepted:

09.08.2021

Close metadata

References:

  1. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 — 11 March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---11-march-2020
  2. World Health Organization. Estimating mortality from COVID-19.  https://www.who.int/news-room/commentaries/detail/estimating-mortality-from-COVID-19
  3. Johns Hopkins University. Coronavirus Resource Center. 2020 Apr 13. Accessed February 01, 2021. https://coronavirus.jhu.edu
  4. Fried JA, Ramasubbu K, Bhatt R, et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020;141:1930-1936.
  5. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239-1242.
  6. Lu Y, Wang P, Zhou T, et al. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States. J Am Heart Assoc. 2018;7(3):e007462.
  7. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497-506. 
  8. Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020;141:1903-1914.
  9. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation. 2020;141:1648-1655.
  10. Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020;75:2352-2371.
  11. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17:259-260. 
  12. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol. 2020;5:831-840. 
  13. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17:543-558. 
  14. Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016;36:78-80. 
  15. Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Investig. 2009;39:618-625. 
  16. Li SS, Cheng CW, Fu CL, et al. Left ventricular performance in patients with severe acute respiratory syndrome: A 30-day echocardiographic follow-up study. Circulation. 2003;108:1798-1803.
  17. Yu CM, Wong RS, Wu EB, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82: 140-144. 
  18. Wu CI, Postema PG, Arbelo E, et al. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes. Heart Rhythm. 2020;17(9): 1456-1462.
  19. Qian Z, Travanty EA, Oko L, et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48:742-748. 
  20. Goulter AB, Goddard MJ, Allen JC, Clark KL. ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2004;2(19):15151696.
  21. Crackower MA, Sarao R, Oudit GY, et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822-828. 
  22. Oudit GY, Kassiri Z, Patel MP, et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res. 2007;75:29-39. 
  23. Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J Biol Chem. 2008;283:3272-3280.
  24. Meng X, Yang J, Dong M, et al. Regulatory T cells in cardiovascular diseases. Nat Rev Cardiol. 2016;13:167-179. 
  25. Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71:762-768. 
  26. Fioranelli M, Bottaccioli AG, Bottaccioli F, et al. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based. Front Immunol. 2018;9:2031.
  27. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet. 2020;395:1054-1062.
  28. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
  29. Libby P, Simon DI. Inflammation and thrombosis: The clot thickens. Circulation. 2001;103:1718-1720.
  30. Caforio AL, Pankuweit S, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636-2648.
  31. Ma K-L, Liu Z-H, Cao C-F, et al. COVID-19 Myocarditis and Severity Factors: An Adult Cohort Study. medRxiv. 2020.
  32. Chen C, Zhou Y, Wang DW. SARS-CoV-2: A potential novel etiology of fulminant myocarditis. Herz. 2020;45:230-232. 
  33. Kociol RD, Cooper LT, Fang JC, et al. Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association. Circulation. 2020;141:69-92. 
  34. Luetkens JA, Isaak A, Zimmer S, et al. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2020;13:e010897.
  35. Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. J Am Coll Cardiol. 2018;72: 3158-3176.
  36. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:1:3-14. 
  37. Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis. Journal of the American College of Cardiology. 1989;14:915-920. 
  38. Beigel JH, Tomashek KM, Dodd LE, et al. Remdesivir for the Treatment of COVID-19 — Final Report. N Engl J Med. 2020;383: 1813-1826.
  39. Huang X, Sun Y, Su G, Li Y, Shuai X. Intravenous Immunoglobulin Therapy for Acute Myocarditis in Children and Adults. Int Heart J. 2019;60:359-365. 
  40. Shen C, Wang Z, Zhao F, et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020;323: 1582-1589.
  41. Evans PC, Rainger GE, Mason JC, et al. Endothelial dysfunction in COVID-19: A position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res. 2020;116:2177-2184.
  42. Chavez S, Long B, Koyfman A, Liang SY. Coronavirus Disease (COVID-19): A primer for emergency physicians. Am J Emerg Med. 2020;44:220-229. 
  43. Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci. 2020;248:117477.
  44. Page RL 2nd, O’Bryant CL, Cheng D, et al. Drugs That May Cause or Exacerbate Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016;134:e32-69. 
  45. Tonnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy — a review of the literature. Immunopharmacol Immunotoxicol. 2013;35:434-442. 
  46. Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63:364-374. 
  47. Peretto G, Sala S, Rizzo S, et al. Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. J Am Coll Cardiol. 2020;75:1046-1057.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.